David Charles Baker - 13 Aug 2025 Form 4 Insider Report for GRI Bio, Inc. (GRI)

Role
Director
Signature
/s/ Leanne Kelly, Attorney-in-Fact
Issuer symbol
GRI
Transactions as of
13 Aug 2025
Net transactions value
$0
Form type
4
Filing time
14 Aug 2025, 16:58:34 UTC
Previous filing
24 Jan 2025
Next filing
27 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baker David Charles Director C/O GRI BIO, INC., 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA /s/ Leanne Kelly, Attorney-in-Fact 14 Aug 2025 0001844060

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $0 +4,527 $0.000000 4,527 13 Aug 2025 Common Stock 4,527 $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant.